[The management of hyperuricemia associated with drug treatment of hypertension].
Second Department of Internal Medicine, Sapporo Medical College.
T
T
Nakata
O
O
Iimura
D000138:Acidosis / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000493:Allopurinol / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001581:Benzothiadiazines; D004232:Diuretics; D006801:Humans; D011339:Probenecid / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood*
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014527:Uric Acid; D000493:Allopurinol; D011339:Probenecid; D013442:Sulfinpyrazone